Supreme Pharmaceuticals (OTC PINK:SPRWF)(CSE:SL) said it has appointed John Fowler as the president of the company, while also electing him to the board of directors.
Fowler, previously director of operations, began working in the medical marijuana sector over 10 years ago, pursuing a career in law to assist medical marijuana patients with legal issues ancilliary to medical marijuana use.
The company said he most recently worked at a prominent Toronto law firm.
Supreme also announced it has appointed Dr. Youbin Zheng, an associate professor and environmental horticulture chair at the University of Guelph, to its advisory board. According to Supreme, he has years of experience in horticulture research, especially in vegetable and ornamental plant production in greenhouses in Canada, England, Japan and China.
The news follows Supreme's announcement last week that it is now ready for the final step prior to being approved for a production license at its Kincardine medical marijuana facility in Ontario, delivering on expectations laid out at the beginning of 2014.
The company completed the security and infrastructure upgrades at the greenhouse facility, and is ready to participate in the Health Canada pre-license inspection, though no date had yet been set as of Friday last week.
Supreme has been working steadily over the past year to develop Kincardine, and with strong support from the local community, it has been able to move quickly to implement its proposed plan since receiving the largest conditional pre-approval from Health Canada in January.
The company is planning to produce up to 24 million grams of medical marijuana at the 342,000 square foot Kincardine facility, and has had to build up the facility to meet regulatory requirements.